|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
23
|
|
pubmed:dateCreated |
2005-12-2
|
|
pubmed:abstractText |
p27 protein is regarded as a valuable prognostic biomarker in cancer with a potential use as a molecular target. However, different methods of immunohistochemical assessment have yielded conflicting results. Here, we sought to determine the prognostic value of p27 in ovarian cancer using a novel method of compartmentalized in situ protein analysis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:BamiasArisA,
pubmed-author:CampRobert LRL,
pubmed-author:DimopoulosMeletios AMA,
pubmed-author:EfstathiouEleniE,
pubmed-author:KassarMohamadM,
pubmed-author:KowalskiDianeD,
pubmed-author:MarkakisSophiaS,
pubmed-author:PsyrriAmandaA,
pubmed-author:RimmDavid LDL,
pubmed-author:WeinbergerPaul MPM,
pubmed-author:YuZiweiZ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
8384-90
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16322299-Adult,
pubmed-meshheading:16322299-Aged,
pubmed-meshheading:16322299-Aged, 80 and over,
pubmed-meshheading:16322299-Cell Differentiation,
pubmed-meshheading:16322299-Cohort Studies,
pubmed-meshheading:16322299-Combined Modality Therapy,
pubmed-meshheading:16322299-Cyclin-Dependent Kinase Inhibitor p27,
pubmed-meshheading:16322299-Cystadenocarcinoma, Serous,
pubmed-meshheading:16322299-Female,
pubmed-meshheading:16322299-Humans,
pubmed-meshheading:16322299-Middle Aged,
pubmed-meshheading:16322299-Neoplasm Staging,
pubmed-meshheading:16322299-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:16322299-Ovarian Neoplasms,
pubmed-meshheading:16322299-Prognosis,
pubmed-meshheading:16322299-Subcellular Fractions,
pubmed-meshheading:16322299-Survival Rate,
pubmed-meshheading:16322299-Tissue Array Analysis,
pubmed-meshheading:16322299-Tumor Markers, Biological
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
|
|
pubmed:affiliation |
Department of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut 06520, USA. diamando.psyrri@yale.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
